PAR PHARMACEUTICAL COMPANIES, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
PAR PHARMACEUTICAL COMPANIES, INC. reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$33.95 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2015-08-06
- PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2015-06-30 was $2.78M.
- PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2015-03-31 was -$36.73M, a 200.95% decline year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-09-30 was $27.20M, a 121.01% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-06-30 was -$12.38M.
- PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2011 was $39.20M, a 381.34% increase from fiscal 2010.
- PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2010 was $8.14M, a 22.58% increase from fiscal 2009.
- PAR PHARMACEUTICAL COMPANIES, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2009 was $6.64M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2015-06-30 | $2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$33.95M 10-Q · filed 2015-08-06 | ||
| 2015-03-31 | -$36.73M 10-Q · filed 2015-05-11 | |||
| 2014-09-30 | $27.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $14.82M derived: sum of 2 quarters · filed 2015-08-06 | $51.21M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | -$12.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $24.01M 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | $36.39M 10-Q · filed 2015-05-11 | |||
| 2013-09-30 | $12.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $6.93M derived: sum of 2 quarters · filed 2014-11-12 | $29.19M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | -$5.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $16.88M 10-Q · filed 2014-08-11 | ||
| 2013-03-31 | $22.26M 10-Q · filed 2014-05-15 | |||
| 2012-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $32.13M 10-Q · filed 2012-08-02 | $32.52M derived: sum of 3 quarters · filed 2012-08-02 | -$125.21M derived: sum of 4 quarters · filed 2012-08-02 |
| 2012-03-31 | $30.13M 10-Q · filed 2012-05-08 | $30.51M derived: sum of 2 quarters · filed 2012-05-08 | -$127.21M derived: sum of 3 quarters · filed 2012-05-08 | -$128.01M derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-12-31 | $382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$157.34M derived: sum of 2 quarters · filed 2012-02-28 | -$158.14M derived: sum of 3 quarters · filed 2012-08-02 | $39.20M 10-K · filed 2012-02-28 |
| 2011-09-30 | -$157.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$158.52M derived: sum of 2 quarters · filed 2012-08-02 | $38.82M 10-Q · filed 2011-11-02 | $25.52M derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-06-30 | -$794.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $196.54M 10-Q · filed 2012-08-02 | $183.25M derived: sum of 3 quarters · filed 2012-08-02 | $185.60M derived: sum of 4 quarters · filed 2012-08-02 |
| 2011-03-31 | $197.34M 10-Q · filed 2012-05-08 | $184.04M derived: sum of 2 quarters · filed 2012-05-08 | $186.39M derived: sum of 3 quarters · filed 2012-05-08 | $202.45M derived: sum of 4 quarters · filed 2012-05-08 |
| 2010-12-31 | -$13.29M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$10.95M derived: sum of 2 quarters · filed 2012-02-28 | $5.11M derived: sum of 3 quarters · filed 2012-02-28 | $8.14M 10-K · filed 2012-02-28 |
| 2010-09-30 | $2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $18.40M derived: sum of 2 quarters · filed 2011-11-02 | $21.44M 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $16.06M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-08-03 | $19.09M 10-Q · filed 2011-08-03 | ||
| 2010-03-31 | $3.03M 10-Q/A · filed 2011-05-06 | |||
| 2009-12-31 | $6.64M 10-K · filed 2012-02-28 |